{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:44:52Z","timestamp":1789839892142,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"am","delay-in-days":665,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015103","name":"Japan Racing Association","doi-asserted-by":"publisher","award":["JRA 2023"],"award-info":[{"award-number":["JRA 2023"]}],"id":[{"id":"10.13039\/100015103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jpba.2023.115600","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T01:48:10Z","timestamp":1690163290000},"page":"115600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["First evidence of the incorporation of daprodustat and other hypoxia-inducible factor stabilizers into equine hair by passive transfer based on segmental quantitative analysis"],"prefix":"10.1016","volume":"235","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-1894","authenticated-orcid":false,"given":"Hideaki","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2729-2392","authenticated-orcid":false,"given":"Mariko","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-9135","authenticated-orcid":false,"given":"Kanichi","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Wakuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary Ngai-Wa","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jpba.2023.115600_bib1","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s40265-020-01384-y","article-title":"Daprodustat: first approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2023.115600_bib2","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.0000000000000184","article-title":"What is the role of daprodustat in treatment of anemia in people on maintenance dialysis?","author":"Berns","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jpba.2023.115600_bib3","unstructured":"International Agreement on Breeding, Racing And Wagering And Appendixes (January 2022). \u3008https:\/\/www.ifhaonline.org\/resources\/ifAgreement.pdf\u3009, 2022 (accessed May 10, 2023)."},{"key":"10.1016\/j.jpba.2023.115600_bib4","unstructured":"2023 Equine Prohibited Substances List. \u3008https:\/\/inside.fei.org\/sites\/default\/files\/2023%20Prohibited%20Substances%20List.pdf\u3009, 2023 (accessed May 10, 2023)."},{"issue":"28","key":"10.1016\/j.jpba.2023.115600_bib5","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1007\/s00216-022-04347-2","article-title":"Generic approach for the discovery of drug metabolites in horses based on data-dependent acquisition by liquid chromatography high-resolution mass spectrometry and its applications to pharmacokinetic study of daprodustat","volume":"414","author":"Ishii","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"issue":"8","key":"10.1016\/j.jpba.2023.115600_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9050","article-title":"Detection and longitudinal distribution of GW1516 and its metabolites in equine hair for doping control using liquid chromatography\/high-resolution mass spectrometry","volume":"35","author":"Ishii","year":"2021","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"7","key":"10.1016\/j.jpba.2023.115600_bib7","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/dta.3247","article-title":"Long-term monitoring of IOX4 in horse hair and its longitudinal distribution with segmental analysis using liquid chromatography\/electrospray ionization Q Exactive high-resolution mass spectrometry for the purpose of doping control","volume":"14","author":"Ishii","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2023.115600_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/bkad057","article-title":"Segmental analysis and long-term monitoring of vadadustat in equine hair for the purpose of doping control","author":"Ishii","year":"2023","journal-title":"J. Anal. Toxicol."},{"issue":"36","key":"10.1016\/j.jpba.2023.115600_bib9","first-page":"5480","article-title":"Hair analysis in forensic toxicology: an updated review with a special focus on pitfalls","volume":"23","author":"Kintz","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.jpba.2023.115600_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/dta.2766","article-title":"Hair testing for doping agents. What is known and what remains to do","volume":"12","author":"Kintz","year":"2020","journal-title":"Drug Test. Anal."},{"issue":"5","key":"10.1016\/j.jpba.2023.115600_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jat\/bkad015","article-title":"Recent trends in MALDI-MS drugs analysis in human hair: pre-analytical and analytical challenges and pitfalls","volume":"47","author":"Kernalleguen","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2023.115600_bib12","doi-asserted-by":"crossref","unstructured":"M. Dunnett, The diagnostic potential of equine hair: A comparative review of hair analysis for assessing nutritional status, environmental poisoning, and drug use and abuse, in: J.D. Pagan (Ed.) Kentucky Equine Research nutrition conferences, 2001, pp. 85\u2013106.","DOI":"10.7313\/UPO9781908062161.009"},{"key":"10.1016\/j.jpba.2023.115600_bib13","unstructured":"M. Popot, S. Boyer, P. Maciejewski, P. Garcia, L. Dehennin, Y. Bonnaire, Approaches to the detection of drugs in horse hair, In R.B. Williams, E. Houghton, and J.F. Wade, (Eds.), Proceedings of the 13th International Conference of Racing Analysts and Veterinarians Cambridge, UK, 2000, R & W Publications (Newmarket) Limited, 2001, pp. 115\u2013120."},{"key":"10.1016\/j.jpba.2023.115600_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117395","article-title":"First detection\/quantification of roxadustat in hair with a new liquid chromatography with tandem mass spectrometry method: application to a treated patient","volume":"546","author":"Alvarez","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jpba.2023.115600_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ckj\/sfy014","article-title":"Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis","volume":"12","author":"Meadowcroft","year":"2019","journal-title":"Clin. Kidney J."},{"issue":"2","key":"10.1016\/j.jpba.2023.115600_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/dta.3172","article-title":"Comprehensive metabolic study of IOX4 in equine urine and plasma using liquid chromatography\/electrospray ionization Q Exactive high-resolution mass spectrometer for the purpose of doping control","volume":"14","author":"Ishii","year":"2022","journal-title":"Drug Test. Anal."},{"issue":"10","key":"10.1016\/j.jpba.2023.115600_bib17","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2174\/1389200223666220825093945","article-title":"Pharmacokinetic study of vadadustat and high-resolution mass spectrometric characterization of its novel metabolites in equines for the purpose of doping control","volume":"23","author":"Ishii","year":"2022","journal-title":"Curr. Drug Metab."},{"issue":"24","key":"10.1016\/j.jpba.2023.115600_bib18","doi-asserted-by":"crossref","first-page":"16989","DOI":"10.3390\/ijerph192416989","article-title":"RGB-depth camera-based assessment of motor capacity: normative data for six standardized motor tasks","volume":"19","author":"Rohling","year":"2022","journal-title":"Int J. Environ. Res Public Health"},{"issue":"12","key":"10.1016\/j.jpba.2023.115600_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s002040050348","article-title":"Hair analysis for drugs of abuse. XIII. Effect of structural factors on incorporation of drugs into hair: the incorporation rates of amphetamine analogs","volume":"70","author":"Nakahara","year":"1996","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jpba.2023.115600_bib20","unstructured":"Assessment report for Duvroq tablets 1, 2, 4, and 6 mg (in Japanese). \u3008https:\/\/www.pmda.go.jp\/drugs\/2020\/P20200619003\/340278000_30200AMX00505_A100_1.pdf\u3009, (accessed May 10, 2023)."},{"issue":"2","key":"10.1016\/j.jpba.2023.115600_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2746\/0425164044868620","article-title":"The beta-agonist clenbuterol in mane and tail hair of horses","volume":"36","author":"Schlupp","year":"2004","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.jpba.2023.115600_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2020.06.019","article-title":"Controlled drug delivery for alopecia: a review","volume":"325","author":"Salim","year":"2020","journal-title":"J. Control Release"},{"issue":"1\u20132","key":"10.1016\/j.jpba.2023.115600_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2006.02.019","article-title":"State of the art in hair analysis for detection of drug and alcohol abuse","volume":"370","author":"Pragst","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2023.115600_bib24","unstructured":"M. Dunnett, S. Tracey, K. Warboys, P. Lees, Drug deposition in equine anagen and telogen hair, in: P.H. Albert, T. Morton, J.F. Wade (Eds.) Proceedings of the 15th International Conference of Racing Analysts and Veterinarians Dubai, United Arab Emirates, 2004, R & W Publications (Newmarket), 2005, pp. 502\u2013508."},{"issue":"1\u20133","key":"10.1016\/j.jpba.2023.115600_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0379-0738(93)90256-A","article-title":"Mechanisms of drug incorporation into hair","volume":"63","author":"Henderson","year":"1993","journal-title":"Forensic Sci. Int"},{"issue":"1","key":"10.1016\/j.jpba.2023.115600_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF03035708","article-title":"Hair analysis for drugs of abuse. VII. The incorporation rates of cocaine, benzoylecgonine and ecgonine methyl ester into rat hair and hydrolysis of cocaine in rat hair","volume":"68","author":"Nakahara","year":"1994","journal-title":"Arch. Toxicol."},{"issue":"9","key":"10.1016\/j.jpba.2023.115600_bib27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1248\/bpb.18.1223","article-title":"Hair analysis for drugs of abuse. X. Effect of physicochemical properties of drugs on the incorporation rates into hair","volume":"18","author":"Nakahara","year":"1995","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2023.115600_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12917-016-0709-5","article-title":"Long-term monitoring of opioid, sedative and anti-inflammatory drugs in horse hair using a selective and sensitive LC-MS\/MS procedure","volume":"12","author":"Madry","year":"2016","journal-title":"BMC Vet. Res"},{"key":"10.1016\/j.jpba.2023.115600_bib29","unstructured":"Assessment report for VAFSEO tablet 150 mg and 300 mg (in Japanese). \u3008https:\/\/www.pmda.go.jp\/drugs\/2020\/P20200619002\/400315000_30200AMX00509_A100_1.pdf\u3009, (accessed May 10, 2023)."},{"key":"10.1016\/j.jpba.2023.115600_bib30","series-title":"Cells - Molecules and Mechanisms","author":"Wong","year":"2009"},{"issue":"20","key":"10.1016\/j.jpba.2023.115600_bib31","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1021\/acs.jpcb.7b02914","article-title":"Predicting a Drug's membrane permeability: a computational model validated with in vitro permeability assay data","volume":"121","author":"Bennion","year":"2017","journal-title":"J. Phys. Chem. B"},{"issue":"4","key":"10.1016\/j.jpba.2023.115600_bib32","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/ani13040670","article-title":"Hydroelectrolytic and acid-base parameters after 80 to 115 km endurance races (Raid Uruguayo) and their association with the comfort index","volume":"13","author":"Marichal","year":"2023","journal-title":"Animals (Basel)"},{"issue":"3","key":"10.1016\/j.jpba.2023.115600_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40262-021-01095-x","article-title":"Clinical pharmacokinetics and pharmacodynamics of roxadustat","volume":"61","author":"Czock","year":"2022","journal-title":"Clin. Pharm."},{"issue":"2","key":"10.1016\/j.jpba.2023.115600_bib34","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.120.265181","article-title":"Nonclinical characterization of the hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat, a novel treatment of anemia of chronic kidney disease","volume":"374","author":"Del Balzo","year":"2020","journal-title":"J. Pharm. Exp. Ther."},{"issue":"12","key":"10.1016\/j.jpba.2023.115600_bib35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/cpdd.1029","article-title":"Clinical pharmacokinetics of daprodustat: results of an absorption, distribution, and excretion study with intravenous microtracer and concomitant oral doses for bioavailability determination","volume":"10","author":"Mahar","year":"2021","journal-title":"Clin. Pharm. Drug Dev."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:06:52Z","timestamp":1777572412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523003692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":35,"alternative-id":["S0731708523003692"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115600","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First evidence of the incorporation of daprodustat and other hypoxia-inducible factor stabilizers into equine hair by passive transfer based on segmental quantitative analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115600"}}